Cargando…

Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles

The spread of coronavirus disease 2019 (COVID-19) throughout the world has resulted in stressful healthcare burdens and global health crises. Developing an effective measure to protect people from infection is an urgent need. The blockage of interaction between angiotensin-converting enzyme 2 (ACE2)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Canhao, Xu, Qin, Wang, Huiyuan, Tu, Bin, Zeng, Jiaxin, Zhao, Pengfei, Shi, Mingjie, Qiu, Hong, Huang, Yongzhuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427979/ https://www.ncbi.nlm.nih.gov/pubmed/34522576 http://dx.doi.org/10.1016/j.apsb.2021.09.004

Ejemplares similares

Author correction to “Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles” [Acta Pharmaceutica Sinica B 12 (2022) 1523–1533]
por: Wu, Canhao, et al.
Publicado: (2023)

Engineered small extracellular vesicles displaying ACE2 variants on the surface protect against SARS‐CoV‐2 infection
por: Kim, Hark Kyun, et al.
Publicado: (2022)

Engineering Extracellular Vesicles Enriched with Palmitoylated ACE2 as COVID‐19 Therapy
por: Xie, Feng, et al.
Publicado: (2021)

SARS-CoV-2 pan-variant inhibitory peptides deter S1-ACE2 interaction and neutralize delta and omicron pseudoviruses
por: Shah, Masaud, et al.
Publicado: (2022)

Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2
por: Nie, Jianhui, et al.
Publicado: (2020)

A Simplified SARS-CoV-2 Pseudovirus Neutralization Assay
por: Donofrio, Gaetano, et al.
Publicado: (2021)

Inhibition of SARS-CoV-2 pseudovirus invasion by ACE2 protecting and Spike neutralizing peptides: An alternative approach to COVID19 prevention and therapy
por: Chen, Jiang, et al.
Publicado: (2021)

Extracellular vesicles containing ACE2 efficiently prevent infection by SARS‐CoV‐2 Spike protein‐containing virus
por: Cocozza, Federico, et al.
Publicado: (2020)

Establishment of a well-characterized SARS-CoV-2 lentiviral pseudovirus neutralization assay using 293T cells with stable expression of ACE2 and TMPRSS2
por: Neerukonda, Sabari Nath, et al.
Publicado: (2021)

Teicoplanin inhibits Ebola pseudovirus infection in cell culture
por: Wang, Yizhuo, et al.
Publicado: (2016)

Antitumor synergism between PAK4 silencing and immunogenic phototherapy of engineered extracellular vesicles
por: Lu, Mei, et al.
Publicado: (2023)

Robust neutralization assay based on SARS-CoV-2 S-protein-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressing BHK21 cells
por: Xiong, Hua-Long, et al.
Publicado: (2020)

A high-throughput SARS-CoV-2 pseudovirus multiplex neutralization assay
por: Sievers, Benjamin Louis, et al.
Publicado: (2022)

Inhaled heparin polysaccharide nanodecoy against SARS-CoV-2 and variants
por: Tu, Bin, et al.
Publicado: (2022)

A simple and safe antibody neutralization assay based on polio pseudoviruses
por: Jiang, Zheng, et al.
Publicado: (2018)

Application of pseudovirus system in the development of vaccine, antiviral-drugs, and neutralizing antibodies
por: Xiang, Qi, et al.
Publicado: (2022)

Lenalidomide downregulates ACE2 protein abundance to alleviate infection by SARS-CoV-2 spike protein conditioned pseudoviruses
por: Su, Siyuan, et al.
Publicado: (2021)

Packaging of Rift Valley fever virus pseudoviruses and establishment of a neutralization assay method
por: Li, Yuetao, et al.
Publicado: (2018)

Genetically Engineered MRI-Trackable Extracellular Vesicles as SARS-CoV-2 Mimetics for Mapping ACE2 Binding In Vivo
por: Galisova, Andrea, et al.
Publicado: (2022)

Evaluation of a Pseudovirus Neutralization Assay for SARS-CoV-2 and Correlation with Live Virus-Based Micro Neutralization Assay
por: Tolah, Ahmed Majdi K., et al.
Publicado: (2021)

Ciliary extracellular vesicles are distinct from the cytosolic extracellular vesicles
por: Mohieldin, Ashraf M., et al.
Publicado: (2021)

The Impact on Infectivity and Neutralization Efficiency of SARS-CoV-2 Lineage B.1.351 Pseudovirus
por: Kim, Yeong Jun, et al.
Publicado: (2021)

Deletion of the SARS-CoV-2 Spike Cytoplasmic Tail Increases Infectivity in Pseudovirus Neutralization Assays
por: Yu, Jingyou, et al.
Publicado: (2021)

Developing Pseudovirus-Based Neutralization Assay against Omicron-Included SARS-CoV-2 Variants
por: Sun, Hancong, et al.
Publicado: (2022)

Azelastine inhibits viropexis of SARS-CoV-2 spike pseudovirus by binding to SARS-CoV-2 entry receptor ACE2
por: Ge, Shuai, et al.
Publicado: (2021)

Synergy in monoclonal antibody neutralization of HIV-1 pseudoviruses and infectious molecular clones
por: Miglietta, Riccardo, et al.
Publicado: (2014)

High-throughput analysis of anti-poliovirus neutralization antibody titre in human serum by the pseudovirus neutralization test
por: Arita, Minetaro, et al.
Publicado: (2022)

Essentials of extracellular vesicles: posters on basic and clinical aspects of extracellular vesicles
por: Nieuwland, Rienk, et al.
Publicado: (2018)

Engineered ACE2 receptor traps potently neutralize SARS-CoV-2
por: Glasgow, Anum, et al.
Publicado: (2020)

Engineered ACE2 receptor traps potently neutralize SARS-CoV-2
por: Glasgow, Anum, et al.
Publicado: (2020)

Calibration of Two Validated SARS-CoV-2 Pseudovirus Neutralization Assays for COVID-19 Vaccine Evaluation
por: Huang, Yunda, et al.
Publicado: (2021)

Calibration of Two Validated SARS-CoV-2 Pseudovirus Neutralization Assays for COVID-19 Vaccine Evaluation
por: Huang, Yunda, et al.
Publicado: (2021)

Evaluation of Immunogenicity by Pseudovirus Neutralization Assays for SARS‐CoV‐2 Variants after Primary and Booster Immunization
por: Xie, Hui, et al.
Publicado: (2022)

Calibration of two validated SARS-CoV-2 pseudovirus neutralization assays for COVID-19 vaccine evaluation
por: Huang, Yunda, et al.
Publicado: (2021)

Establishment of a pseudovirus neutralization assay based on SARS-CoV-2 S protein incorporated into lentiviral particles
por: Wang, Sheng, et al.
Publicado: (2022)

Repositioning of histamine H(1) receptor antagonist: Doxepin inhibits viropexis of SARS-CoV-2 Spike pseudovirus by blocking ACE2
por: Ge, Shuai, et al.
Publicado: (2021)

P04-10. Neutralization of Tier 1 and Tier 2 pseudoviruses by human anti-V3 monoclonal antibodies
por: Gorny, MK, et al.
Publicado: (2009)

Antibodies Targeting Two Epitopes in SARS-CoV-2 Neutralize Pseudoviruses with the Spike Proteins from Different Variants
por: Yang, Chee-Hing, et al.
Publicado: (2021)

A pseudovirus-based platform to measure neutralizing antibodies in Mexico using SARS-CoV-2 as proof-of-concept
por: Cruz-Cardenas, José Antonio, et al.
Publicado: (2022)

Comparison of VSV Pseudovirus and Focus Reduction Neutralization Assays for Measurement of Anti-Andes orthohantavirus Neutralizing Antibodies in Patient Samples
por: Vial, Cecilia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3sdii6oncv33ek1cklqhejvobd